Potential gene therapies bring hope to patients with sickle cell disease

Arecent analysis highlights how potential gene therapies have the potential to dramatically reduce income disparities for patients with sickle cell disease, leading to as much as $21,000 more in average income in the year following gene therapy administration alone.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Medicines in Development Health Equity Source Type: news